The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats

J Hypertens. 2006 Aug;24(8):1589-97. doi: 10.1097/01.hjh.0000239295.17636.6e.

Abstract

Objective: Leptin attenuates the angiotensin II-induced increase of cytosolic calcium ([Ca2+]i) and vasoconstriction in the aorta of normotensive Wistar rats. To determine whether these effects may be altered in hypertension, we assessed the effect of leptin on angiotensin II-induced vascular response in the aorta of 10-week-old spontaneously hypertensive rats (SHR).

Methods: Contractile responses to angiotensin II (100 nmol/l) in the presence of different concentrations of leptin (0.1, 1, 10, 100 nmol/l) were evaluated in isolated aortic rings by the organ bath system. [Ca2+]i was measured in vascular smooth muscle cells (VSMCs) using Fura-2 fluorescence. The expression of the short (OB-Ra) and long (OB-Rb) isoforms of the leptin receptor in VSMCs was evaluated by real-time reverse transcriptase-polymerase chain reaction and western-blot analysis.

Results: Circulating leptin concentrations were increased in SHR. Serum metabolic parameters, including glucose, insulin, total cholesterol and triglyceride levels, were also elevated in SHR. Leptin did not modify the angiotensin II-induced vasoconstriction in SHR either in intact or endothelium-denuded aortic rings. In addition, leptin was not able either to diminish the angiotensin II-induced the peak rise of [Ca2+]i or to accelerate the recovery rate to basal calcium levels in VSMCs from SHR. However, OB-Ra and OB-Rb mRNA and protein expression were increased in SHR VSMCs.

Conclusions: The lack of effect of leptin on angiotensin II-induced contraction in the aorta of SHR is due to an impaired handling of [Ca2+]i in VSMCs. Hyperleptinemia and overexpression of OB-R in VSMCs could be compensatory mechanisms against VSMC leptin resistance in genetically hypertensive rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Angiotensin II / metabolism*
  • Animals
  • Aorta / drug effects
  • Aorta / physiopathology
  • Biomarkers / blood
  • Blotting, Western
  • Calcium / metabolism
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Hypertension / metabolism
  • Hypertension / physiopathology
  • Leptin / administration & dosage
  • Leptin / metabolism*
  • Male
  • Muscle, Smooth, Vascular / blood supply*
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / metabolism
  • Protein Isoforms / biosynthesis
  • Protein Isoforms / drug effects
  • RNA, Messenger / drug effects
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Inbred SHR
  • Rats, Wistar
  • Receptors, Cell Surface / biosynthesis
  • Receptors, Cell Surface / drug effects
  • Receptors, Leptin
  • Reverse Transcriptase Polymerase Chain Reaction
  • Vasoconstriction / drug effects*

Substances

  • Biomarkers
  • Leptin
  • Protein Isoforms
  • RNA, Messenger
  • Receptors, Cell Surface
  • Receptors, Leptin
  • Angiotensin II
  • Calcium